Pursuant to Regulation 44 (3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Syschem (India) has informed that it enclosed the details of the Voting Results of the Extra-ordinary General Meeting (EGM) held on 17th June, 2022 as per the prescribed format. Further, as required under Section 108 & 109 of the Companies Act, 2013 read with Rule 20 & 21 of the Companies (Management and Administration) Rules, 2014, as amended from time to time, the report of the Scrutinizer on remote e-voting process is also enclosed herewith. As per the Report, the resolutions are passed with requisite majority.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.20 |
| Dr. Reddys Lab | 1233.00 |
| Cipla | 1232.25 |
| Zydus Lifesciences | 937.65 |
| Lupin | 2328.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: